Novo Nordisk Launches Higher-Dose Wegovy Weight-Loss Shot in U.S. WSJNovo Nordisk launches higher-dose Wegovy in the United States ReutersNovo Undercuts Lilly With High-Dose Wegovy at $399 a Month Bloomberg.com
Wegovy beats Foundayo in Novo Nordisk weight loss study qz.com
Novo Nordisk's explosive Wegovy pill launch draws a new wave of patients into GLP-1 weight loss treatment CNBC
FDA Approves Foundayo, a Wegovy Alternative GLP-1 Pill for Weight Loss Healthline
Sudden Sight Loss Risk Almost 5x Higher With Wegovy Than Ozempic, Study Finds sciencealert.com
NHS England to offer weight-loss drugs to 1.2m people to reduce risk of heart attacks and strokes The Guardian
Ozempic and Wegovy users reveal harrowing dark side of ‘miracle’ weight-loss drugs the-independent.com
Ozempic Is About to Go Generic for Billions of People The New York Times
A new weight-loss pill is here. Here's how Foundayo compares to Wegovy, Zepbound, and other GLP-1 rivals. Business Insider
The FDA approves a new obesity pill, giving patients another option NPR
Novo Nordisk's Wegovy® HD available now nationwide PR Newswire
Novo Nordisk launches high-dose Wegovy statnews.com
Wegovy ‘HD’ Dose Is Here—How To Find GLP-1 Medications And Compare Costs Forbes
Wegovy HD Now Available in the U.S. Pharmaceutical Executive
Race for weight loss dominance intensifies as Novo launches stronger Wegovy dose Fox Business
Wegovy HD 7.2mg Now Available for Chronic Weight Management Medical Professionals Reference
The weight-loss drug rivalry heats up as another GLP-1 pill gains FDA approval Scientific American
Novo launches high-dose Wegovy in the US; Evotec pressured to list its US unit Endpoints News
EXCLUSIVE: New Subscription Program for Wegovy Could Save Patients $1,200 a Year — How to Access It TODAY.com
Pills or Shots for Obesity? New Foundayo Pills vs. Oral Wegovy The People's Pharmacy
Wegovy® pill demonstrated greater weight loss than orforglipron and lower odds of stopping medication due to side effects in a new indirect comparison to be presented at Obesity Medicine Association 2026 PR Newswire
Wegovy HD Now Available in the U.S. | PharmExec Pharmaceutical Executive
Wegovy Launches New Subscription—How to Save Up to $1,200 Forbes
Novo Nordisk says Wegovy pill outperforms Lilly’s oral GLP-1 in cross-trial comparison CNBC
Novo Nordisk launches higher-dose Wegovy in the United States By Reuters Investing.com
Foundayo vs. oral Wegovy: The similarities, the differences and what you need to know Managed Healthcare Executive
FDA Approves Higher-Dose Wegovy To Help People Lose More Weight Infectious Disease Advisor
Foundayo vs. Wegovy: How Do the New Weight Loss Pills Compare? SELF Magazine
Novo Nordisk launches first and only multi-month subscription program for FDA-approved Wegovy®, offering savings of up to $1,200/year PR Newswire
Novo Nordisk cuts Ozempic, Wegovy prices in India again to fight cheaper generics Reuters
Novo Nordisk’s higher-dose Wegovy HD launches in the US The Independent
Novo's Wegovy cleared by UK drug price watchdog for heart disease, expanding access by 1.2 million people CNBC
Novo Nordisk Launches Higher Dose Of Wegovy Injection Across US — Retail Thinks Stock Is ‘Terribly Undervalued’ Stocktwits
Trump's Iran deadline, the Altman-Musk feud, Novo's Wegovy pill and more in Morning Squawk CNBC
Danske Bank on the Wegovy tablet: Novo needs higher prescription rates to meet its targets this year medwatch.com
Novo says indirect data favour its Wegovy pill over Lilly's new obesity entrant FirstWord Pharma
Novo Nordisk to launch discounted Wegovy subscriptions for self-pay patients in US Reuters
Novo Nordisk Says Wegovy HD Available Now Across US TradingView
Novo Nordisk launches multi-month subscriptions for Wegovy obesity drugs as it tries to catch up with Eli Lilly CNBC
FDA approves new daily GLP-1 pill — how they compare to Wegovy tablets New York Post